Come join the Family Office Networks Webinar Series featuring Revance. Revance Therapeutics (NASDAQ: RVNC) is a Silicon Valley-based biotechnology company, pioneering new innovations in neuromodulators for aesthetic and therapeutic indications.
Daring to Make a Difference in Aesthetics and Therapeutics
Come join the Family Office Networks Webinar Series featuring Revance. Revance Therapeutics (NASDAQ: RVNC) is a Silicon Valley-based biotechnology company, pioneering new innovations in neuromodulators for aesthetic and therapeutic indications. Tobin Schilke, Chief Financial Officer and Dustin Sjuts, Chief Commercial Officer, Aesthetics & Therapeutics, will speak about the advantages of its next-generation neuromodulator, DaxibotulinumtoxinA for Injection, not only for wrinkle reduction, but also in the treatment of debilitating medical conditions.
What you will learn from this webinar:
Potential for Revance’s new, long-lasting neuromodulator product in aesthetics and therapeutics.
Details on Revance’s premium dermal fillers and fintech services now launching into prestige dermatologic and plastic surgery practices.
News on Revance’s program with Mylan to develop a biosimilar to BOTOX®.
BOTOX® is a registered trademark of Allergan, Inc.
